The conference will stream live on Tuesday, February 28, at 8:30 AM EST Tel Aviv, Israel / Vancouver, Canada, Feb. 08, 2023 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND), (FSE: CWY) (“Clearmind” or “the Company”), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, will host a virtual…

Source

Previous articleOpinions | Australia’s Rescheduling of MDMA and Psilocybin a Welcome First Step, Potential International Catalyst
Next articleBullseye Chart: The Psychedelic Drug Development Pipeline